Medizinische Hochschule Hannover, Hannover Medical School

Hanover 30625

1 studies enrolling now · 3 studies all time

What they study most

Essential Thrombocythemia, Melanoma, Metastatic or Unresectable Cutaneous Melanoma

Studies at this site

• A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia — Recruiting now
• Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma — Completed
• Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma — Completed